The ABCORA 2.0 test allows for a parallel assessment of IgG, IgM, and IgA reactivity to multiple antigens enabling a high-dimensional temporal resolution of antibody responses and a dissection between humoral responses to an infection and vaccination. This evidence concerns the gene CD79A and infection.